Navigation Links
Mammograms May Boost Cancer Risk in High-Risk Women
Date:12/1/2009

Radiation exposures in younger women may up chances of disease, study finds

TUESDAY, Dec. 1 (HealthDay News) -- Mammograms may actually boost the risk of breast cancer in some high-risk women, a new study suggests.

Dutch researchers analyzed six previously published studies, four examining the effect of low-dose radiation exposure from mammography among women with the genetic mutation boosting breast cancer risk and two looking at the effect of radiation from screening in women with a family history of breast cancer.

"Women who were exposed before the age of 20 had a 2.5 times increased risk of breast cancer," said Martine Jansen-van der Weide, an epidemiologist and researcher at the University Medical Center Groningen, in the Netherlands. So did women with five or more exposures.

She was to present the findings Monday at the Radiological Society of North America's annual meeting in Chicago.

No information was available from the studies about the time period, said Jansen-van der Weide. The studies did control for different factors that affect breast cancer risk, such as age, breast-feeding and age at first menstruation.

These new findings come in the wake of a controversial recommendation made in mid-November by the U.S. Preventive Services Task Force for the general public, that women delay routine screening mammograms from age 40 to 50, asking their doctor the best time to begin, and that older women switch to every-other-year mammograms.

Currently, the American Cancer Society and other organizations advise yearly mammograms for women beginning at age 40. For high-risk women, the ACS recommends a mammogram and MRI every year.

Overall, the Dutch researchers also found, the average risk of breast cancer from radiation exposure was 1.5 times greater among the high-risk women studied than the high-risk women not exposed.

The study is important, as it provides the ''first direct piece of evidence on whether high-risk women have an increased risk due to radiation exposure," said Edward Hendrick, a member of the American College of Radiology Commission, a medical physicist and clinical professor at the University of Colorado at Denver.

In the United States, women under 30 don't routinely get mammograms, however, he said. It's known that young women are more radiation-sensitive.

Young women who are deemed high-risk can, if they choose, turn to an MRI breast exam instead, he said. MRIs use magnetic or radio waves, not radiation.

"Screening is very important," Jansen-van der Weide said. "However, for young, high-risk women, a careful approach is advised when considering mammography for screening."

More information

To learn more about guidelines for early detection of cancer, visit the American Cancer Society.



SOURCES: Martine C. Jansen-van der Weide, Ph.D., epidemiologist, University Medical Center Groningen, Netherlands; Edward Hendrick, Ph.D., member, American College of Radiology Breast Imaging Commission, and clinical professor, University of Colorado at Denver; Nov. 30, 2009, presentation, Radiological Society of North America annual meeting, Chicago


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. SIRIUS XM to Broadcast Doctor Radio Reports: What Every Woman Needs To Know About Mammograms
2. Guidelines Delay Start of Mammograms to Age 50, Then Every Other Year
3. Guidelines Push Back Start of Mammograms to Age 50, Then Every Other Year
4. Researchers believe hormone therapy should not be stopped prior to mammograms
5. More Mammograms May Mean More Harmless Cancers
6. Mom Offers Personal Mother's Day Message on Importance of Annual Mammograms
7. Susan G. Komen Funds Mammograms for Saints Mary and Elizabeth Medical Center
8. Fewer Women Are Having Mammograms
9. Childhood Cancer Survivors Not Getting Recommended Mammograms
10. Interpretation time for screening digital mammograms: Is it efficient?
11. Mammograms may detect some cancers that would have otherwise regressed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology: